ENZ On Other Exchanges
New York
text size: T | T
Back to Snapshot
Company Description

Contact Info

527 Madison Avenue

New York, NY 10022

United States

Phone: 212-583-0100


also supports its approximately 9,000 products through a global network of dedicated distributors. Axxora.com: Axxora.com is a distribution platform for original manufacturers of research reagents. The products supplied by Enzo Life Sciences include small molecules, proteins, antibodies, peptides, probes, assay kits and custom services. The company’s comprehensive portfolio of reagents and kits in key research areas are sold to scientific experts in various fields, such as adipokines, antibiotics; apotosis/cell death, biologically active peptides, bone metabolism, cancer research, cell death, cell cycle, chemokines/cytokines, cytoskeletal research, dependence receptors, DNA fragmentation/damage/repair, DNA regulation, epigenetics, FISH, growth factors/cytokines, hypoxia, immunology, viral signaling, inflammation/innate immunity, interferons, in vitro toxicology, kinases/inhibitors, leukotrienes/prostaglandins/thromboxanes, microarray labeling, multidrug resistance, natural products/antibiotics, neuroscience, nitric oxide pathway, nuclear receptors, oxidative stress, protein aggregation, proteosome/ubiquitin, receptors, signal transduction, stem cell/cell differentiation, stress proteins/heat shock proteins, toxicology, TNF/TNF receptor superfamily, and transcription factors. Enzo: The original Enzo brand products and technologies are primarily focused in the areas of microarray analysis, gene regulation and gene modification. Patented Enzo technologies and products are recognized as key tools in non-radioactive gene and protein labelling. Alexis: The Alexis brand provides recognition in producing and commercializing reagents and as an established source for a panel of products in many key research areas, including the fields of cell death, nitric oxide, and obesity/adipogenesis. Biomol International: The Biomol International brand provides global recognition in the cellular biochemistry segment with an emphasis on areas related to protein post-translational modification, be it by ubiquitin or the ubiquitin-like proteins, acetylation, methylation, phosphorylation, sulphation, or glycolsylation. Assay Designs: The Assay Designs brand emphasizes the company’s immunoassay development capability in the fields of inflammation, steroids and hormones, and cell signalling. Stressgen: The Stressgen brand is focused on the fields of the heat shock and cell stress. Enzo Life Sciences through its selective new product development programs is entering new markets in the fields of Cellular Analysis and Protein Aggregation detection. As part of this introduction, the company established new product lines to increase recognition of its products, such as the Cellestial range of fluorescent dyes and kits, and ProteoStat protein aggregation detection line of products. The company is also launching certain products, particularly new drug development assays and immunoassay kits developed or acquired through its business collaborators. Strategy The key elements of the company’s strategy are to increase investment in research and development and product development; continue to commercialize new platforms for molecular diagnostics via multiple channels; maximize its resources by collaborating with others in research and commercialization activities; exploit its marketing and distribution infrastructure; and expand and protect its intellectual property estate. Research and Development For the year ended July 31, 2015, the company incurred costs of approximately $3.4 million for research and development activities. Sales and Marketing The company’s sales and marketing strategy for Enzo Life Sciences is to sell its life science products through direct sales to end-users under the Enzo Life Sciences name, with direct recognition to its acquired brands; direct sales to end users under the Axxora electronic market place name; supply agreements with manufacturers; and distributors in major geographic markets. The company’s direct marketing and sales network includes fully-owned subsidiaries, a branch office in France, and a network of third party distributors in various other markets worldwide. The company m


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

ENZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ENZ.
View Industry Companies

Industry Analysis


Industry Average

Valuation ENZ Industry Range
Price/Earnings 17.2x
Price/Sales 3.0x
Price/Book 5.7x
Price/Cash Flow 17.2x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ENZO BIOCHEM INC, please visit www.enzo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.